α-Blockers for uncomplicated ureteric stones

Näytä kaikki kuvailutiedot

Permalink

http://hdl.handle.net/10138/290318

Lähdeviite

Vermandere , M , Kuijpers , T , Burgers , J S , Kunnamo , I , van Lieshout , J , Wallace , E , Vlayen , J , Schoenfeld , E , Siemieniuk , R A , Trevena , L , Zhu , X , Verermen , F , Neuschwander , B , Dahm , P H , Tikkinen , K A O , Aubrey-Bassler , K , Vernooij , R W M , Aertgeerts , B & Bekkering , G E 2018 , ' α-Blockers for uncomplicated ureteric stones : a clinical practice guideline ' BJU International , vol. 122 , no. 6 , pp. 924-931 . https://doi.org/10.1111/bju.14457

Julkaisun nimi: α-Blockers for uncomplicated ureteric stones;
a clinical practice guideline
Tekijä: Vermandere, Mieke; Kuijpers, Ton; Burgers, Jako S.; Kunnamo, Ilkka; van Lieshout, Jan; Wallace, Emma; Vlayen, Joan; Schoenfeld, Elizabeth; Siemieniuk, Reed A.; Trevena, Lyndal; Zhu, Xiaoye; Verermen, Francis; Neuschwander, Ben; Dahm, Philipp H.; Tikkinen, Kari A. O.; Aubrey-Bassler, Kris; Vernooij, Robin W. M.; Aertgeerts, Bert; Bekkering, Gertrude E.
Muu tekijä: University of Helsinki, Dep. of Obstetrics and Gynaecology (Institute of Clinical Medicine) (-2009)
University of Helsinki, Department of Surgery
Kuuluu julkaisusarjaan: BJU International
ISSN: 1464-4096
Tiivistelmä: Objective To develop an evidence-based recommendation concerning the use of alpha-blockers for uncomplicated ureteric stones based on an up-to-date Cochrane review, as the role of medical expulsive therapy for uncomplicated ureteric stones remains controversial in the light of new contradictory trial evidence. Methods We applied the Rapid Recommendations approach to guideline development, which represents an innovative approach by an international collaborative network of clinicians, researchers, methodologists and patient representatives seeking to rapidly respond to new, potentially practice-changing evidence with recommendations developed according to standards for trustworthy guidelines. Results The panel suggests the use of alpha-blockers in addition to standard care over standard care alone in patients with uncomplicated ureteric stones (weak recommendation based on low-quality evidence). The panel judged that the net benefit of alpha-blockers was small and that there was considerable uncertainty about patients' values and preferences. This means that the panel expects that most patients would choose treatment with alpha-blockers but that a substantial proportion would not. This recommendation applies to both patients in whom the presence of ureteric stones is confirmed by imaging, as well as patients in whom the diagnosis is made based on clinical grounds only. Conclusion The Rapid Recommendations panel suggests the use of alpha-blockers for patients with ureteric stones. Shared decisionmaking is emphasised in making the final choice between the treatment options.
URI: http://hdl.handle.net/10138/290318
Päiväys: 2018-12
Avainsanat: alpha-blockers
ureteric stones
clinical practice guideline
MANAGEMENT
TAMSULOSIN
LOCATION
PASSAGE
SIZE
3126 Surgery, anesthesiology, intensive care, radiology
Tekijänoikeustiedot:


Tiedostot

Latausmäärä yhteensä: Ladataan...

Tiedosto(t) Koko Formaatti Näytä
Vermandere_et_al_2018_BJU_International.pdf 244.6KB PDF Avaa tiedosto

Viite kuuluu kokoelmiin:

Näytä kaikki kuvailutiedot